Project Coordinator: Prof. Maria Bryszewska. Organisation: University of Lodz, Poland
This project has received funding from the following National Funding Organizations:
National Science Centre (NCN) Poland; State Education Development Agency (VIAA) Latvia,
under grant agreement No. UMO-2018/30/Z/NZ1/0091.
The controlled delivery of drugs to the brain remains a challenge in the effective treatment of neurodegenerative diseases due to the role played by the endothelial barrier. The endothelial barrier is an important part of the body. It consists of the layer of the special cells organized in a complex system. This barrier surrounds our vessels and protects the body tissues from unwanted visitors: microbes and toxic substances. However, the fact that this barrier recognizes all substances as intruding species causes a huge medical problem in treatment for many severe brain diseases, among them the Alzheimer disease.
The project aims to develop the nanoformulations based on dendrimers, dendrons or gold nanoparticles which will overcome the endothelial barrier resulting in the effective and specific delivery of therapeutic substances.
. . .
This site, and its content with confidential information that is intended for the exclusive use of NanoTENDO project partners and other authorized persons. Only authorized employees and partners are permitted to access this web site and any unauthorized use of given information is unlawful. The information and material contained on this site is confidential, and all authorized persons accessing the material have an obligation of confidentiality. If you are not an authorized employee or partner of the NanoTENDO project, you are hereby notified that any entry into this site or disclosure, copying, distribution or use of any of the information contained in or attached to this site is strictly prohibited. If you have any knowledge of attempts to enter this site wrongfully, please immediately notify us via e-mail at email@example.com